Lancashire and South Cumbria
Formulary
Formulary
3 Respiratory system
When prescribing inhalers the drug, device (e.g. MDI, Easibreathe, Autohaler, Accuhaler), strength (micrograms per inhalation), number of puffs per dose and frequency MUST be specified
03-04-01 Sedating antihistamines
| Chlorphenamine maleate |
|
Formulary
|
Tablets 4mg |
 LSCMMG: Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy MHRA: Over-the-counter cough and cold medicines for children |
|
| Hydroxyzine hydrochloride |
|
Formulary
|
Tablets 10mg, 25mg |
|
MHRA: Hydroxyzine (Atarax, Ucerax): risk of QT interval prolongation and Torsade de Pointes |
|
|
| Promethazine Phenergan® |
|
Formulary
|
| Tablets 10mg, 25mg Liquid 5mg/5mL |
|
MHRA: Over-the-counter cough and cold medicines for children |
|
|
Links
- NICE TA10: Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma
- Asthma action plan child: Asthma UK
- Asthma management plan: Asthma UK
- LSCMMG: Asthma Treatment Guideline for Adults
- LSCMMG: Asthma Treatment Guideline for Children
- LSCMMG: Chronic Obstructive Pulmonary Disease (COPD) Desktop Guideline
- LSCMMG: Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy
- LSCMMG: Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy
- LSCMMG: Position statement on the prescribing of antihistamines and nasal sprays for mild to moderate hay fever and allergic rhinitis on prescription
- MART asthma plan
- MHRA Drug Safety Update :Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists
- MHRA: Hydroxyzine (Atarax, Ucerax): risk of QT interval prolongation and Torsade de Pointes
- MHRA: Over-the-counter cough and cold medicines for children
- MHRA: Over-the-counter cough and cold medicines for children
- MHRA: Pressurised metered dose inhalers (pMDI): risk of airway obstruction from aspiration of loose objects
- NICE advice [ESUOM31]: Chronic urticaria: off-label doses of cetirizine
- NICE Evidence Summary: Rapid tranquillisation in mental health settings: promethazine hydrochloride
- NICE NG115: Chronic obstructive pulmonary disease in over 16s: diagnosis and management
- NICE NG209: Tobacco: preventing uptake, promoting quitting and treating dependence
- NICE NG80:Asthma: diagnosis, monitoring and chronic asthma management
- NICE TA38: Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years)